CANF - Can-Fite BioPharma Ltd.

NYSE American - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 510.5M
Enterprise Value 31.53M
Trailing P/E N/A
Forward P/E 1-0.79
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.01
Price/Book (mrq)1.50
Enterprise Value/Revenue 30.44
Enterprise Value/EBITDA 6-0.28

Trading Information

Stock Price History

Beta (3Y Monthly) 1.80
52-Week Change 3-83.06%
S&P500 52-Week Change 36.92%
52 Week High 325.9500
52 Week Low 32.6600
50-Day Moving Average 32.9457
200-Day Moving Average 310.7538

Share Statistics

Avg Vol (3 month) 3251.69k
Avg Vol (10 day) 3104.78k
Shares Outstanding 53.32M
Float 1.11M
% Held by Insiders 10.00%
% Held by Institutions 121.13%
Shares Short (Jun 28, 2019) 4207.14k
Short Ratio (Jun 28, 2019) 40.33
Short % of Float (Jun 28, 2019) 4N/A
Short % of Shares Outstanding (Jun 28, 2019) 46.23%
Shares Short (prior month May 31, 2019) 486.09k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 215/1
Last Split Date 3May 10, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -191.63%
Operating Margin (ttm)-158.79%

Management Effectiveness

Return on Assets (ttm)-34.67%
Return on Equity (ttm)-125.20%

Income Statement

Revenue (ttm)3.49M
Revenue Per Share (ttm)2.52
Quarterly Revenue Growth (yoy)-52.70%
Gross Profit (ttm)3.82M
Net Income Avi to Common (ttm)-6.68M
Diluted EPS (ttm)-4.8000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.21M
Total Cash Per Share (mrq)2.1
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.75
Book Value Per Share (mrq)2.13

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A